ࡱ> 5@PGbjbj22"XXP?HHHHtVIlow2JJJJJKKKvvvvvvv$xRzzwKKKKKwJJ)wfffKT JJvfKvfff.ofqJJ P !HVp4qD?w0ow2q4m{dBm{hfqm{fqDKKfKKKKKww>B f B2nd International Conference "Genomics, Proteomics and Bioinformatics for Medicine"  14-19 July, 2004 Moscow - Ples - Moscow, Russia  Second announcement Internet: http://www.ibmh.msk.su/gpbm2004 E-mail: gpbm2004@ibmh.msk.su Organized by: International Union of Biochemistry and Molecular Biology (IUBMB) The Human Proteome Organisation (HUPO) Russian Ministry of Industry, Science and Technology Russian Ministry of Health Russian Academy of Medical Sciences Russian Foundation for Basic Research The Russian Biochemical Society Moscow Committee on Science and Technology Institute of Biomedical Chemistry of Rus. Acad. Med. Sci. International Science and Technology Center RHUPO General Sponsor: Bruker Group of Companies Sponsored by: OAO Passenger Port Janssen Research Foundation Thermofinnigan Ciphergen BiosystemsBioRad Carl-Ceiss NC-Group NT-MDTOrganizing Committee: Pokrovskiy V.I. (Chairman) Archakov A.I. (Vice-Chairman) Kirpichnikov M.P. (Vice-Chairman) Sister V.G. (Vice-Chairman) Bagirov E.B. Egorov A.M. Govorun V.M. Ivanov A.S. Khaitov R.M.Poroikov V.V. Nikolaev E.N. Podoplelov A.V. Lisitsa A.V. Lyakhovich V.V.Tkachenko S.B. Tsyganov D.I. Tuteljan V.A. Voitkevich N.D.International Scientific Committee: Bairoch A. Bochkov N.P. Debabov V.G. Estabrook R. Ferst A. Franzen J. Georgiev G.P. Grigorjev A.I.Hanash S. Hoschtrasser D. Ivanov V.T. Lewi P. Kelly S. Kovalchuk M.V. Lopukhin Yu.M.Masters B.S. Nicolini C. Omura T. Petrov R.V. Sagdeev R.Z. Schmid R. Skrjabin K.G. Sverdlov E.D.Local Committee: Poroikov V.V. (Chairman) Guseva M.K. (Vice-Chairman) Beyer E.M. (Secretary) Agababova I.S. Berestova O.N. Bodoev N.V.Bylinkina V.S. Fedoronchuk T.V. Grigoryan E.A. Ipatova O.M. Isaeva G.V. Ivanova O.A.Molnar A.A. Semenova N.V. Sugokon V.V. Tarasova E.A. Zgoda V.G.Mail address: GPBM 2004 Institute of Biomedical Chemistry RAMS Pogodinskaya Street, 10 Moscow, 119121, Russia  TOPICS: 1. Genomics 1.1. Genome individuality and human genotyping. 1.2. SNPs in diagnostics of human diseases. 1.3. Complete microbial genomes and hostpathogen interactions. 2. Proteomics 2.1. Human proteome index: myth or reality? 2.2. Serum biomarkers as diagnosticums of human diseases. 2.3. Proteomics as a basis for new drug targets validation. 3. Bioinformatics 3.1. Bioinformatics as a basis for integrative computational biology. 3.2. Computer-aided drug discovery. 3.3. Bioinformatics application of grids and clusters. WORKSHOPS 4.1. Peptidomics 4.2. Cytochromes P450 superfamily 4.3. ISTC Special Session 4.4. Emerging technologies Call for Abstracts Delegates to GPBM2004 are encouraged to submit Abstracts describing oral presentations. Accepted abstracts will be published in the Abstract Book, which will be available to all participants. The deadline for abstract submission is April 16, 2004. Abstract submission Typing should be 12-point Times New Roman, single-spaced. 1. Title - should be typed in capital letters (ALL CAPS). 2. Author's names - full first name, middle initial, last name (in that order). Indicate author affiliations by superscripts (if authors are from more than a single affiliation) and underline the name of the presenting author. 3. Authors' affiliations and addresses. Please provide also e-mail address of the presenting author. 4. Leave an empty line between affiliations and the abstract text. 5. The Abstract text - should be within 300 words in length, no indentations. 6. Save the file - as "Your_name.rtf" for submission in Rich Text Format. Abstracts should be submitted electronically by e-mail (as attached RTF files) to the Conference Secretariat at: gpbm2004@ibmh.msk.su. Faxed abstracts will not be accepted under any circumstances. Abstract acceptance Notification of acceptance will be submitted to the corresponding author by April 20, 2004. Please note that the abstract will not be accepted unless the presenting author is registered. All accepted papers will be presented at the sessions of the Conference as a lectures or oral communications. No Poster Session is suggested. Time for lectures: 30 min. Time for oral presentations: 15-20 min. Time-table will be prepared after consummation of the treaty with Navigation Company. Language: The official language of the Conference is English. Preliminary Program 1. Genomics Wilhelm Ansorge, EMBL, Heidelberg, Germany HUMAN GENOME CHIP IN BIOMEDICAL APPLICATIONS Evgeny Sverdlov, Institute of Molecular Genetics of Russian Academy of Sciences, Moscow, Russia GENOMICS AND COMPLEX DISEASES Iqbal U. Ali, National Cancer Institute, Bethesda, MD, USA SNPS-BASED ASSOCIATION STUDIES IN CANCER SCREENING AND PREVENTION Nikolay Kolchanov, Institute of Cytology and Genetics of Rus. Acad. Sci., Novosibirsk, Russia AN INTEGRATED COMPUTER SYSTEM FOR STUDING THE REGULATION OF EUCARYOTIC GENE EXPRESSION Steven Kelly, University of Wales, UK UNDERSTANDING YEAST STEROL BIOSYNTHESIS; DRUG TARGETS AND CONTROL Vladimir Tumanyan, Institute of Molecular Biology of Rus. Acad. Sci., Moscow, Russia SNPs AND HUMAN DISEASES Rolf Schmid, Institute for Technical Biochemistry, University of Stuttgart, Germany MICROARRAYS FOR THE RAPID DIAGNOSIS OF ANTIBIOTICS IN A CLINICAL ENVIRONMENT SEASES Mikhail Gelfand, Institute of Problems for Information Transmission of Rus. Acad. Sci, Moscow, Russia COMPARATIVE GENOMICS OF BACTERIAL REGULATORY SYSTEMS AS THE BASIS FOR CREATION OF NEW MEDICIN ES Sergey B. Zotchev, Department of Biotechnology, NTNU; SINTEF Industrial Biotechnology, Trondheim, Norway GENERATION OF NOVEL ANTIBIOTICS VIA MANIPULATION OF THE NYSTATIN BIOSYNTHETIC GENE CLUSTER IN THE BACTERIUM STREPTOMYCES NOURSEI  2. Proteomics Samir Hanash, University of Michigan, Ann Arbor, USA. FUNCTIONAL PATHWAY ANALYSIS IN CANCER USING INTEGRATED GENOMICS AND PROTEOMICS. Jan Humphery-Smith, University of Utrecht, The Netherlands. THE ENTIRE HUMAN PROTEOME AND ITS RELEVANCE TO THE ESTABLISHMENT OF 'SELF' AND 'NON-SELF' DURING LYMPHOCYTE ONTOGENY. Andrey Shevchenko, Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Germany. MULTIORGANISMAL PERSPECTIVE IN FUNCTIONAL PROTEOMICS. Claudio Nicolini, University of Genova and Fondazione Elba, Rome, Italy NEW AVENUES IN STRUCTURAL PROTEOMICS. Vadim Govorun, Institute of Physical-Chemical Medicine of Russian Ministry of Healthcare & Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia POSTGENOMIC TECHNOLGIES IN RESEARCH OF PATHOGENIC MICROORGANISMS Fuchu He, Beijing Institute of Radiation Medicine, China. PROTEOME AND INTEGRATION WITH ITS TRANSCRIPTOME OF HUMAN FETAL LIVER. Andrey Lisitsa, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia REVERSE ENGINEERING OF PROTEIN RELATIONSHIPS ON THE BASICS OF 2D-PAGE DATA Pierre S. Paroutaud, Applera, France PROTEOMICS: DIFFERENT APPROACHES, DIFFERENT 'TOOLS' Young-Ki Paik, Yonsei Proteome Research Center & Biomedical Proteome Research Center, Korea. PROTEOMIC ANALYSIS OF CHOLESTEROL METABOLISM IN NEMATODES.  3. Bioinformatics Rolf Apweiler, European Bioinformatics Institute (EBI), Hinxton, Cambridge, UK. STANDARDISATION AND INTEGRATION: DRIVING FORCES IN BIOINFORMATICS FOR PROTEOMICS AND GENOMICS Peter Schuster, Institut fuer Theoretische Chemie und Molekulare Strukturbiologie der Universitaet Wien, Wien, Austria RNA - A MAGIC MOLECULE AT THE INTERPLAY OF STRUCTURAL BIOLOGY, BIOINFORMATICS, AND EVOLUTION Marc Nicklaus, NIH/NCI, Frederick, MD, USA. NEW IDENTIFIERS AND TOOLS IN CHEMOINFORMATICS Paul Lewi, Center for Molecular Design, Beerse, Belgium TEN YEARS OF COMPUTER-AIDED DESIGN OF HIV1-REVERSE TRANSCRIPTASE INHIBITORS. HOW FAR DID WE GO? Sergey Varfolomeev, Chemistry Department of Moscow State University, Moscow, Russia BIOINFORMATICS AND CHEMISTRY OF ENZYMATIC CATALYTICAL CYCLE Kyoung Tai No, Computer Aided Molecular Design Research Center, Seoul, Korea IN SILICO PREDICTION OF ABSORPTION, METABOLISM AND TOXICITY Vladimir Poroikov, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia ALLIANCE OF BIO- AND CHEMOINFORMATICS IN COMPUTER-AIDED DRUG DISCOVERY Boris S. Zhorov, Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada IN SILICO ACTIVATION AND BLOCK OF ION CHANNELS Nadya Tarasova, National Cancer Institute- Frederick, Maryland, USA CHEMICAL KNOCK-OUT OF POLYTOPIC MEMBRANE PROTEINS AS A MEANS OF DRUG TARGET VALIDATION AND DRUG DEVELOPMENT Masato Kitajima, Osaka University, Fujitsu Kyushu System Engineering Limited, Osaka, Japan Interaction Search between Proteins and Ligands by Database Integration with Grid Technology SPECIAL WORKSHOPS:  4.1. Peptidomics Per Anden, Uppsala University, Sweden. A PEPTIDOMICS APPROACH OF EXPERIMENTAL PARKINSON'S DISEASE. Peter Schulz-Knappe, BioVisioN AG, Hannover, Germany. PEPTIDOMICS: BIOMARKER DISCOVERY IN BODY FLUIDS AND TISSUES. Vadim Ivanov, Institute of Bioorganic Chemistry of Rus. Acad. Sci., Moscow, Russia PEPTIDOMICS AS A NEW BRANCH OF POSGENOMIC TECHNOLOGIES Ekaterina F. Kolesanova, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia PEPTIDE SCANNING AS A TOOL OF PEPTIDOMICS APPROACH AND ITS APPLICATION TO SYNTHETIC VACCINE DESIGN  4.2. Cytochromes P450 superfamily Julian Peterson, UT Southwestern Medical Center, USA. USING SEQUENCE ANALYSIS TO RATIONALLY REDESIGN A P450. Alexis Ivanov, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia TRENDS AND NEW PERSPECTIVES IN 3D MODELLING OF CYTOCHROMES P450 Rita Bernhardt, Universitaet des Saarlandes, Saarbrucken, Germany. NEW INSIGHTS INTO STRUCTURE AND FUNCTION OF STEROID HYDROXYLASES AND POTENTIAL APPLICATION IN MEDICINE. Victor Zgoda, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia EFFECT OF P450 INDUCERS ON MOUSE LIVER PROTEOME Victoria Shumjantseva, Institute of Biomedical Chemistry of Rus.Acad. Med.Sci., Moscow, Russia ARTIFICIAL CATALYTIC CYCLE OF CYTOCHROME P450: APPLICATION FOR ELECTROCHEMICAL SYSTEMS Sergey Usanov, Institute of Bioorganic Chemistry, National Academy of Sciences, Belarus GENOMICS AND PROTEOMICS OF STEROIDOGENESIS Semen Gusev, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia CYTOCHROME P450 KNOWLEDGEBASE: INTEGRATING THE HETEROGENOUS DATA AND METHODS Vyacheslav Lyakhovich, Novosibirsk, Russia STUDY OF CYTOCHROME P450 2B GENE ACTIVATION DURING INDUCTION BY PB-TYPE COMPOUNDS John Richards, California Institute of Technology CYTOCHROME P450, MECHANISM OF ACTION 4.3. ISTC Special Session Sergey Netessov, NPO Vector, Koltsovo, Russia. THE STUDY OF PREVALENCE, GENOTYPE DISTRIBUTION AND/ MOLECULAR VARIABILITY OF ISOLATES OF HEPATITIS C VIRUS IN THE SIBERIAN PART OF RUSSIA, Project N 1637 Alexander Gabibov, Institute of Bioorganic Chemistry, Moscow, Russia Catalytic Antibody Approach in Development of New Antiviral Therapeutics, Project N 2226 Dmitri Filimonov, Institute of Biomedical Chemistry RAMS, Moscow, Russia. DELAYED NEUROTOXICITY, EARLY DIAGNOSTICS AND NON-EXPERIMENTAL PREDICTING, Project N 0574 Nikolai Sokolov, Institute of Biomedical Chemistry RAMS, Moscow, Russia. DEVELOPMENT OF A NEW ANTITUMORAL DRUG OF RECOMBINANT ERWINIA CAROTOVORA L-ASPARAGINASE: RESULTS AND PROSPECTS OF RESEARCH, Project N 1263 and N 2828. Sergey Varfolomeev, Moscow State University IMMUNOBIOSENSORS BASED ON MAGNETORESISTANCE TECHNOLOGY, Project N 1548 4.4. Emerging technologies Seminar HUPO 4.4.1. Mass-Spectrometry in Biomedical Chemistry Peter J. Derrick, University of Warwick, Coventry, UK EMERGING TECHNOLOGIES FOR PROTEOMICS BASED ON MASS SPECTROMETRY. John B. Fenn, Virginia Commonwealth University, USA ELECTROSPRAY WINGS FOR MOLECULAR ELEFANTS Herbert Thiele, Bruker Daltonik GmbH, Bremen, Germany MASS SPECTROMETRY AND BIOINFORMATICS IN PROTEOMICS Emilio Gelpi, Instituto de Investigaciones Biomedicas de Barcelona, Spain REVISITING OLD HEALTH PROBLEMS WITH PROTEIN BIOMARKERS Richard Simpson, Ludwig Institute of Cancer Research, Parkville, Australia PROTEOMIC ANALYSIS OF COLORECTAL CANCER: STRATEGIES FOR NOVEL BIOMARKER DISCOVERY Evgeni Nikolaev, Institute of Energy Problems of Chemical Physics of Rus. Acad. Sci., Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia POTENTIALS AND PROBLEMS OF FTICR MS APPLICATIONS IN PROTEOMICS Ron M. Heeren, FOM-Institute for Atomic and Molecular Physics, The Netherlands DIRECT MASS SPECTROMETRIC IMAGES OF CELLS AND TISSUES: A NEW ION MICROSCOPE. 4.4.2. Nanobiotechnologies Yoshinobu Baba, Faculty of Pharmaceutical Sciences, The University of Tokushima, Japan. NANO-BIODEVICE FOR GENOMIC MEDICINE AND SYSTEMS BIOLOGY Victor Bykov, NT-MDT, Moscow, Russia DEVELOPMENT OF SCANNING PROBE TECHNIQUE FOR MOLECULAR RESOLUTION RESEARCH Michael Kowalchuk, Institute of Crystallography of Rus. Acad. Sci., Moscow, Russia NANOBIOORGANIC MATERIALS Yuri Ivanov, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia OPTICAL BIOSENSOR STUDY OF COMPLEX FORMATION IN PROTEOMICS Renad Sagdeev, Alexandra Yurkovskaya, Tomography Research Center, Novosibirsk, Russia APPLICATION OF NUCLEAR POLARIZATION TECHNIQUES FOR INVESTIGATION OF STRUCTURE AND DYNAMICS OF BIOPOLYMERS IN SOLUTIONS Alexander Archakov, Institute of Biomedical Chemistry of Rus. Acad. Med. Sci., Moscow, Russia AFM NANOTECHNOLOGIES IN PROTEOMICS  Location: The Conference will be held aboard of the comfortable ship Felix Dzerzhinsky going down the Volga River from Moscow to Ples and back. Participants of the conference and accompanying persons will visit beautiful places of Russian nature and history. Ship Accomodation: Departure. The ship "Felix Dzerzhinsky" will depart from the Moscow Nothern River Station (Metro Station "Rechnoy Vokzal" at 17:30 on July 14, 2004. Boarding: 12:00-17:00. Opening Ceremony will be held at 15:00 on July 14, 2004 at the ship's Conference-Hall. Arrival. Arrival to Moscow is expected on July 19, 2004 at about 20:00. Registration: Please, make your registration on-line via www.ibmh.msk.su/gpbm2004 or fill in the registration form and return it by mail or fax to: +7 (095) 245-0857 The number of participants will be limited. Additional Registration Forms can be obtained on web-site: www.ibmh.msk.su/gpbm2004 The deadline for early registration is May 1, 2004 All changes in the Program will be available on the web-site. Registration fees (in USD/EURO and per person) Before After May 1, May 1, 2004 2004 Commercial 500/400 550/430 Academic1 350/270 400/310 Students2 200/155 250/195 Accompanying person 200/155 250/195 1Academic rate available to full-time employees of academic or government institutions. 2 Subject to verification. Accommodation Fees3 (in USD/EURO) Single room (1st class) 1200/940 Single room (2nd class) 1000/780 Double room (2 persons) 1400/1090 3 Includes river trip, lodging, meals, sightseeing tours and banquet. Passport and visa: To prepare the application for your visa, the Organizing Committee needs the following information about the participant and accompanied persons. 1. Passport copy (main page) for you and your family members (fine quality fax to +7 095 245-0857 or scanned computer image sent by E-mail). 2. First name(s), family name (including all given names). 3. Date of birth: Place of birth: 4. Citizenship and region of current living: 5. Country where you work: 6. Nr.of Passport: Date of validity: 7. Place of work: 8. Position at work: 9. Work address: 10. Arrival date: Departure date: 11. Place of getting the visa: The procedure of visa application is the following. 1. You will send us all information listed above ASAP. 2. We apply for your visa to the Russian Ministry of Foreign Affairs. 3. When the permission for his visa will be obtained (typically, about 2 weeks prior to the visit), we shall send you your personal number that identified this permission. 4. With this number and all necessary documents you will come to the Russian Consulate stipulated in item [11] and get a visa. UVWZ[ 2 H P [ l ˿߬ߣ߆vvlvlvv\h O5B* CJmH phsH hX9CJmH sH h OCJmH sH  h OCJh O5B* CJphh O>*mH sH h OmH sH h O6mH sH  h O6 h O5CJ h O5CJ$jgh O5CJ$Uh OB* CJphh OCJmH sH h Ojh OUh O5B* phh OB* CJ"phUVXYZ[l> e  & Fx^ @&^$dX$ddx $x^a$$ Oa$PG  J  $ 4 I P [ d k  & Fd$Ifd & Fd & Fk l  " . ; I X h sssssiii j $If  j d$If  skd o$$Ifl0r B/  04 la h v sofff d$If<kdo$$IflF 330    4 la j $If  # . < K U e q y  d$If !"/01ES1ƶmYmYmRRHh OCJOJQJ h O5CJ'hX9h O5B*CJhmH phsH $hX9h OB*CJhmH phsH !h O5B*CJhmHphsHh OB* CJhmHphsH!h O5B* CJhmHphsHh Oh OCJmH sH  h OCJ h OCJh O5B* CJphh O5B* CJmH phsH h OCJmH sH h OCJOJQJmH sH /Kbq}ttttttttttt d$Ifkdp$$IflF 330    4 la !";b{vnh__3d^33^3 3xkdq$$IflFj   0    4 la d$If 6DESNr1x^^1)=wCdstG j ^ 7^7`d^<^x^ d<^)=wkuCZNbdstܽܶ楍϶znjh Oh O5B* CJphh O56CJh OCJmH sH /hX9h O59B*CJOJQJmH phsH !h O59B*CJOJQJph h O5CJh O>*CJOJQJ h O>*CJ h OCJ h O6CJh OCJOJQJh O6B* CJphh O59B*CJph'-Z[$If7kdr$$Iflt4 la $$Ifa$ ^^ [\kYZ[lxf`SE:`hPQ5CJOJQJhX9hPQ5CJOJQJhX9hPQCJOJQJ hPQCJ#hX9hPQ5CJOJQJmH sH hX9hPQCJhPQ5CJOJQJaJhX9hPQ5CJOJQJaJh hPQCJOJQJaJ hX9CJhX9hX95CJOJQJhX9hX9CJOJQJ h OCJhX9h O5CJOJQJhX9h OCJOJQJ h O5CJh OCJOJQJ[\YZyky$$Ifa$gdPQ $IfgdPQ7kds$$Iflt4 la $IfgdX97kd@s$$Iflt4 laZ[8z{{{{ $IfgdX97kdTt$$Iflt4 la $IfgdPQ7kds$$Iflt4 laz{|]^oqs3GLMNOP^_Ÿ|ume[Q[hX9CJOJQJh CJOJQJhX9CJaJh CJaJ h 6]h  hX9hX9 hX9]hX9hX9]hX95CJaJh hX95 hX9CJh hX9CJOJQJhX9hX9CJOJQJ hPQCJhPQ5CJOJQJh hPQCJOJQJ h OCJh O5CJOJQJhX95CJOJQJ{|?yyyy $IfgdX97kd u$$Iflt4 la $IfgdPQ7kdt$$Iflt4 la \]^MNwn $Ifgd  7$If]7gdX97kdu$$Iflt4 la $IfgdX97kdhu$$Iflt4 laNOP^_`|||$If7kd|v$$Iflt4 la $$Ifa$7kd v$$Iflt4 la_`l9 : J !!!""$""""##%########x$y$$N%O%\%%%%E&F&X&&&&c'd'u' ( (ڸ¸ګڞ hPQCJhPQ5CJOJQJh hPQCJOJQJh}hX9CJOJQJh CJOJQJhX9CJOJQJh hX95CJOJQJ hX9CJhX95CJOJQJh hX9CJOJQJ hX95CJ5& 8 9 : O7kdw$$Iflt4 la7kd4w$$Iflt4 la$If7kdv$$Iflt4 la : P!!!!!""7kdHx$$Iflt4 la$If7kdw$$Iflt4 la$If ""p"""""##$If7kdy$$Iflt4 la$If7kdx$$Iflt4 la##v#######||| $$Ifa$7kdy$$Iflt4 la$If7kd\y$$Iflt4 la##$w$x$y$$M%N%$If7kdpz$$Iflt4 la$If7kdz$$Iflt4 laN%O%|%%%%%D&E&F&O7kd{$$Iflt4 la7kd({$$Iflt4 la$If7kdz$$Iflt4 la F&&&&&&'b'c'd''( (|7kd<|$$Iflt4 la $IfgdPQ7kd{$$Iflt4 la$If ( (f(((((G)H)xW ,p@ P !$$IfgdPQ7kd|$$Iflt4 la $IfgdPQ $IfgdPQ:kd|$$Ifl4t4 laf4 (f(p((((((((((G)H)I)Z)`)l)v))********,*-*º§џ~wmg]mV hX95CJh CJOJQJ hX9CJhX9CJOJQJ h}5CJh}h}5CJOJQJh}h};h} h}h}h}h}5h}hPQ5CJOJQJ hPQ]h}hPQ] h}hPQh}hPQ5 hPQCJhPQ5CJOJQJ h ahPQh ahPQ6]h ahPQCJOJQJH)I))*****xmm $$Ifa$7kd}$$Iflt4 la $Ifgd} $Ifgd}:kdV}$$Ifl4t4 laf4***+*,*-*U***|||$If7kdp~$$Iflt4 la $$Ifa$7kd~$$Iflt4 la-*6****+ ++++++++ ,,?,Z,[,\,],^,,,ı{shshYOE> hX95CJhX9CJOJQJh CJOJQJh h CJaJmH sH hg0h mH sH h mH sH !hX95CJOJQJaJmH sH 'h h 5CJOJQJaJmH sH !h 5CJOJQJaJmH sH $h h CJOJQJaJmH sH  h CJh 5CJOJQJh h CJOJQJ hX9CJhX95CJOJQJh hX9CJOJQJ***++ +\+++||| $Ifgd 7kd($$Iflt4 la$If7kd~$$Iflt4 la+++[,\,],^,,,xmmm $$Ifa$7kd$$Iflt4 la $$Ifa$gd  $Ifgd 7kd$$Iflt4 la,,,,,,L---||| $IfgdPQ7kd$$Iflt4 la$If7kd<$$Iflt4 la,,,,------:.;.<.H.....%/|/}/~//ʺʪtcTTM@hhCJOJQJ hPQ5CJhPQ5CJOJQJmH sH  hhPQCJOJQJmH sH h}hPQ56CJOJQJh}hPQ5CJOJQJh}hPQCJOJQJhPQ6CJOJQJhPQCJOJQJ hPQCJhPQ5B* CJOJQJphhPQ5CJOJQJhhPQCJOJQJ hX9CJhX95CJOJQJhhX9CJOJQJ---:.;.<....y7kdP$$Iflt4 la $IfgdPQ $IfgdPQ7kd$$Iflt4 la..%/|/}/~//00yyy $Ifgd7kd$$Iflt4 la $IfgdPQ7kd$$Iflt4 la/0000000'1(15171Z1111111111ּ{qj]PChlHhX9CJOJQJhlHhECJOJQJhlHhlHCJOJQJ hX95CJhX9CJOJQJ hX9CJhX95CJOJQJ&h5B*CJOJQJmH phsH h5CJOJQJmH sH hhCJOJQJ hPQ5CJ hPQCJhPQ56CJOJQJhPQ5CJOJQJhhPQCJOJQJ hCJh5CJOJQJ00Z00000&1'17kd$$Iflt4 la $IfgdPQ7kdd$$Iflt4 la'1(1Z111111yy $$Ifa$7kdx$$Iflt4 la $Ifgd7kd$$Iflt4 la11h2i2j223 3 3M9kd$$Ifl#t4 la7kd0$$Iflt4 la$If7kdԃ$$Iflt4 la11111W2i2j2t2{2223 3 333B3S3T33333333q4444444455 5.5/5a5b5r555596:6;6I6666㚼铆hhX9CJOJQJ hX95CJhX9CJOJQJhlH5CJOJQJhlHhlHCJOJQJhX956CJOJQJhlHhX9CJOJQJhlHhECJOJQJ hX9CJhX95CJOJQJhE5CJOJQJ4 33333444455|7kdH$$Iflt4 la $IfgdE7kd$$Iflt4 la$If 55-5.5/5`5a5|qq $$Ifa$7kd$$Iflt4 la$ $If^` a$7kd$$Iflt4 laa5b55555696:6;6O7kd$$Iflt4 la7kd$$Iflt4 la$If7kd\$$Iflt4 la ;6q66666'7(7)7t7777kḋ$$Iflt4 la7kdp$$Iflt4 la$If 66'7(7)78777788888D9F9G9c9d9r999::e:g:h:y::::i;j;w;8<9<K<<<<<====o>ɾ跭蟑Շ{u{u{u h OCJh O5B* CJphh OCJmH sH hX9CJOJQJmH sH hCJOJQJmH sH hX9CJOJQJ hX95CJh5CJOJQJhX9hhX95 hX9CJhX956CJOJQJhX95CJOJQJhhX9CJOJQJ-77h88888E9F9$If7kd$$Iflt4 la$If7kd($$Iflt4 laF9G9b9c9d9999|||$If7kd<$$Iflt4 la $$Ifa$7kd$$Iflt4 la99:f:g:h::::7kd$$Iflt4 la$If$If7kd$$Iflt4 la::-;h;i;j;;7<8<9<O7kd$$Iflt4 la7kd$$Iflt4 la$If7kdP$$Iflt4 la 9<<<<<<<<====n>o>>>>>'? $]^a$$^a$ ^7kdd$$Iflt4 la$Ifo>>>>>>>(?7?b?z????5@6@N@O@@@@@@@ AAAAAA"A#AFAGA`AaAbAAAAAAAA±†}}oo}}h OB* CJmH phsH h O5CJH*h OB* CJphh OCJmH sH h O59B*CJphh OB*CJph!h O59B*CJmH phsH  h O5CJh O5>*B*CJphh O5B*CJphh O5B* CJph h OCJh O5B*CJph+'?(?7???O@P@@@@@@@@@AA#A>AXArAA  d<  d$da$$^a$ $]^a$AA B B.BBBBBBBCCDMD`DtDDDDDDExdd^$da$ Qd^`QQd<^`QA BBB B-B.BBBBBBmCnCCCCCDmEnEEEEFFFG&G>GMGOGPGhCJaJ hh5B*CJaJphhhCJaJ hCJ h O5h Oh OB* CJphh O5CJH*mH sH h OB* CJphh O5CJH*h O5B* CJph h OCJ E$E7ENEmEnENGOGPGx &P . A!"#$%gDd A <  C A2xfD"Ah N8m3 TfD+`!LfD"Ah N8m3 zfx}`TH/DBWĎ"(JWTzHHEBH =l663޹m3n6;;c4 fi&y0J _-PC&7 ˠ}{a F#1Og!=0v;NiyP=%?XȿFg}%;wXw=0 kҾL_@Z1*.Ρ,;{&F ;6 hΛM]d FCyf%3U vOMUGJ*bO N*B ˲Kr촴Ą۷\qgΝ<~bߞwڻ{Ϟ]wڵuֵדu֯]Gُk6lظe={v]?~ęg^p-&[gggf9C@BEU!E# DNOçMH iZSSSn_zԩؾ}u-Yy>~#Go=X֭Ү]w]ת͖f-7lK{f[4_J\q%],? k_N!ç?i3gE^r˶-_.GF޺s'%9՚e-:] BD?ϐ".?PWDL)RXX{gոޗnlj,i={O FN4aVe˖lۼ'ΞJLL$*(w ETGe_nմu&vdCv;^x̩k ]oyeުP)%Dnp0dLT6 &#}db#^~D +ը=1x`DYҏo_tXLiADWv~-Z,{͙]NCN>+|[n;~ד6+9AOW\* Ή-(99ڵGٺqӖzWμꕚĕ)KTds3łH1LTs`!&hx@r{ 5(du.Z&ca X2 s\ܙzuvwߙֳgOaμUV?իDl6!as\aATcR ϕ׭R>$D\¬Ԍo? 2mS߾ڷ_?|"E"׋ ~)vYjr_E{@0J ">ߠ2 U}TZLJWA׉M+zr j:O|1׬Ysk1)OlEyS֓ Cb#w0O `3zGuT"VSaD$|D5]xq]g[_]3T) эo&ׄ!<7ǯ6k(Cc׏T0Ϛ$'F!\2F_AEU$p8/]o-cFzӍrsu7J&ʌiHѮĖHv|lrT jV;;X"2 d줖cIz؈fv*Ke*M@?Ұ  3RڵS y7} V(_'%rn#5Nlb+V:n|^F m.]t:М+d ~^\.Dk{ܽˑ̜unԩc-ZmqvJ }@qSV4ڪ T-;vላ8%mAI0JP³e^ MTX I|Pf1Ni@,wKC'Y@ݒn'N׭AӦ:f/uᒥUYgnoa[Vęwd# j~/{YxCGnݳ(G@0wqk<[lLm[~>(yҥf ~QԖ:&3.YSCH]'ؕeR$|kGsrs]||Ko_)`򗹒7zM)xDe? ~"6 IH|=DȘ Լ\x-R]6A%JPyȤDf+Ͳ^M Uj,vl~Ǐ]nl8^p#W7Vr2ϩ]z&%[: 5( e(Y\<̨J"3`wtL>EUKW<+Gߠp]&N IKFߍQBKceD.b) ^ĄlU~Jrta&_8YY"q+)À3&E_԰@O23D[3l諗OΛ}Ck$R֜Rxܳ~fPG`r$Rc-y; !,+ԟPd gc?qc@jb$5{dwRխ^۫qak6lr)'/G=$,٥KhӿTUM(2 unŞ[[K#*ZPd)OfR+ޙQ٧P6y82pÅ*?M!=ޠO-FxIv ShA#TD5#2xsZnB)RŕZgRظ͛ݼy0#鏑U%s"JvI)goܽ[VrN͉7y/?T0: r!1,"g&UX%qϹh!Mp໷+o2OѪK&o!.IWD?tzkhof͘wrɈ9د_5GIPg>sa5k8M鮦ΰh1Uu"t3b'$Ȏ~DԠ*߹^U tA g+'AgjC^3PxbO׭?G _h٩ G}Nv߽ha| #΋XMBk[6*I$VTeX~`=?@T zro(VH)iT&DsQ].Wɰ/{;jė(eˉ}{Q塉zZKy( di/~=3˕nΤ^aҮOCs8jUh!Dlz, Mݣk=y/LvWN4 2L݃h$l̢fRY )s3sM1ժ}!/ _p9*r%`iC-a/Er&O@HNdI MfQ2B< L$"d)K7@T.?ѵ+QLv!$*Fdri1=>?až{%E 3(O*su?^_cj9 <ObT̍!rʕŧgb9fCٷr!-񅡨fb@#ݻ ??U ץuFe2\^mf t.@xt6- w/&=pa#noU<` Z5+TxG"f*Z1~= +URѴRkڼ>jWsf9w괵0_Q( -\O"?"V,'+;qzdOQ3?l|7xT\)# / 7p ꉟجլ"sd( >ܨw0y333E4*HQ`NRR ORfS}Q,.5Ҁ{hK7# y0+Y`X2aYZFȥ4UNw#۲eKbrzPKɲ'N\_9rMWFJrx+#!A&?,yXз^86t`((go94 Ffs\r>zȑkmHOć3 +%9*E_M?#;3ϥh3 iꎈG|n <UPLjAr2Jg^h|!T酝::xo&a?7zTEX59ё>Z­3y(S1z$Q\<-P2pqJl[q]7Vl0f62H!o+ItU)PbMh^ۙ! k#̯暍E\ E `rZM闌cQ/l*BXVL^t;[Pz}PQ"t}N۴icZf=aw1u/۫g5SHn[|a6T|yb[j\t۝owy<[7kf !:8GBrX`/LMM}Vll1fd9ć 2V@ZS$>r9i⢢o܈u+---.ItB%x\\[5f$I\ej+Alj/7( ACEr\G޽, ^jUϼIE^f+)V4EBr.HJ$o+ 2,&ZGu\e\Qk Mfo>Bfo/ G*RƼ{޽<[Ͳxz7vǑN>#G6+kHQAıAh-6j3u+.BqE #_[ f k2]^}lgNȞ*F{#<vQP=(c@Hϊ HT%/ElL2<  ]jmHV,#=7WNMIxh< Br,E0/0[gS n:zx˘8dst癿s<B!VbŶjIҘ MIiGBe:qr!1gAh{m}&ڵFp{4gb{f/p+Iddl I[\DJOMcoerY[ q*nbsN'|54אU4t旽N>MQKy>JyԨҐ*:9?xCvc< N7>Ț`R 8kheelJo+Q#k]|OefŽo 3+O AE F!Ah0.BE]5jf=]PPRyƀHXEŊtVkT,?5{aǎ}cU$L۳WXȮQgAaxÏR/'& /%hۂoII D9{v_GK?ܗ|;/%?\5kB %W>7w!&"g_,^<$&Nb ui_jmzz*uـ瓹Ms*HOw/9 d'钅:?)rE3n%Kk4%vxco.XyV`D(``j\58W8h8_ѡ?hdʊ> sOأu>uvdEeT*Xwr]Års/3fF%wY%U$F+T*8_c.GFVEn6ebvo"6m)pBI_}}/l YhkѲ@ g6rDwvC+W$NȊ,R"X}\=?`ABB, yEq`_O'B L_y G}JU4qqTg&$>ݺ{QByj@;hQԀ l 'dafb?\<$}܌T&_U=d8Ln:tW 5s̻Z<|؈Rk F)+3{6B4ѢOE-_Q@-20 <9*q1 &!xE`S_lĕ.mۑ>R%rB`XjJO-Q"|h*;T0Ȏ+NoSH->NwJUD\?Lx,fCn`Ϻ= S-+nupUcAP۲}nl\u{lu9c(my]a'.<1ZI 1R_߈sQknS:bJZc :rKA -4^P~;w5 ,P/(fdggdA㦕X ib\%kx5dM^MwM/Y.Ԯcs%MQȅb2xYz}4j8#d\F˵5c1r%ÍwnVX2<5 (v5}q„ W_#HDE,DJ~%WVpbsede1 r*  'L eJU@?k`McoHU`9w-xM)~fȈNP/ñYxm>r$O‚w`baO cEdfm6- /RdU؄IC*JX#k͆oJȝ=S HKbN}^t5#@ʂdZ꠾=.ZF7-++;=7sӏjran0\|?x<,z@2š #i-Wᶳ9xӥ\ܦ g6T&uBW!~Sw-D5ǫ݇",0 Yv/pCG1eKo5k CK<D4\}U:>\ĸ)s }5XP;GcFY9r$0QlD0ZՀ(]@1C)o:[1u(E˧`hD Y1>Q՚1|`>M$Ad0tT?53f}}'1xH"WQ1׎ x_KOi$")Eݛ1%x9 *c`o ԭX fP/%>Fѩ˙tqX (7E_[hS&6 1PPujx25TEpH"NnwjpjHïmx``2N?ҏnݸ^X(6J1SpNUU(ORD`Uz~yjOe_LR"ܯ S4\BSt?CA+$툗 l3">߲wr>C> e)yW'i)OʍOI]>#R?nbܝ[vVD!A:Hȕb\KfxWWvT x^qQ.^uzllbb=Jp30*f"9))iii9u~`!{y9y/OMJOIHIHMJIOIKJ&_c,ȓ\5ĺ ; Y.K.O@%1a^^^9Ԭ ۃ}<')lR#\Pnp3`!ϯWhvxjJ\bPcġ4}{9?\6)q,Fl+0f3*|Q 6gFM>{5=zm1!Ğw׎%?vm۞%.4ټ3G,`ޜs͙xes,=<_8KVX֭Gp>CAA' R<"#,ZxάE֯t^<ōk3{8Q.-X>g6lHOdoetJZYdӥ)<_lyVC5a6gwFT} cKdKKNa/ݺ_nUʕM,]~ٲתV>QW_哱 DYv0!9dxkoDkڼ>gtA}+W'NT5<ݰ/ ܰɆopQ/ym;{ ={>3ۗ*xmޜᇿΗN1ڵkׇƒݦLr77~--ZN;͛TI*`_ehU!8=;;ԍQ^{E5cSc\j綝Ns .1b8:dPVNFJO2BKhPoZf{$FqԬ>m*E'~:(JJ@;[S l1Jw1r#ERW|R2\A8rř&){iw%ŤqȌrZɒ_yeD7hhJy\yӳ'MJO{^Dn]U06njϳSԼ7Z:ǁ Aڰδ%&|jǯp8jZni ˄RVH$qުo3% X=x۷1vYPlҾfMweHXϗQ偃=A"AD3ڪᅪ[5je\^mZ-^ z" eYd"jԘ3yrRb<@;7')׫\PWJ@f ec F&ub+ۛkWUSJzT /WRz7b̙i ϗĒ3 PwFϦ{R2p㆜AmlҳqSh|OM"[8mJP 8d\hWlO GPwaֽ{X73 J eΊeģ ƒ: VdzW"URB&Mx 0=F[9~n*D_iSUNp/MvR®.K `G )Dr, eJ6FT ~, M.6]x3܍}Ty@K:42*#5'!走݊9z P'nYt P˖LW~zfظ22ȝKF^|UՠҪcʕ{bꑞV^ĕkx#L/]vy >JP^OaO2JNy$gi(ߗ+.*Ѭٴ9(<_>GcBobn}"Wh M,Y.%5 6l[\xP7-jyF {-_,?i ݠK x:Hdl_#ۻa~!NܑPNw^AM:>޸G >$J\f[2ϡ/](3'"../y^#M^<ŽϽ˛_yuU>zj/FCgf$K7@t6t}.]x릟mܼuml]fפZ4l$_}eHeFܳh }I8=U׀7rM)<3z]ٌqԔ$r*[\c7*-FիhΜ.}?cFLT ex C&yݷtdɑ%@y0KC m6 c Eqi VP@ :+&ݛi_ކ&}eQ6n8c!JLLYs)Vtsf۵m5ړm<ݨQRnпes55EJe+m' @+CXչs޾s&`&WMj.WO V=6yp`ӹyy~zT$,S, TN׫3kVf9А\i&F<'N8I aC$NA,rS&"M7>|-baF"΢ ,3w lrjL˔wec ^8sh2dƉl'1AE[w\8J}꩛8`+F+Ŧ}QjF:F_6GJU mfMOJH95 oGEJ0yAh?acG ֐@vxx^P$$ӮNI.y"M}[}]FGܡھzcRvp2gqVWҤ(*VDիj5pJjPG$n4QBi?}Ըx_I\ɚ-ސ< &`Vme6+fͼv=P}zq'P": 2}7jM`:ZtBY*W1-Wk*xwߕ͂ i7Թ?84v#8y9Vة#ƪ7YKTʼn}6uW%IQuzR>|w9(džyr^&1rn\m\jU^%U `U_Q9iOQrڲ6 C6~v찁9Pxܰ>Aw8q@1Cp"(82dH+Sr+-|„t#,%meQ0b+TɧsV+WPqAZ3!t/ILJOO 5*H QRc, zLSu+KdcuyĀ>Yc t=RqEL!? 7gSlnq#(ru?MpO`kiB]KR5T䴾}8JA)^khо7;%N܊܈6os:+EB, #91vw?Y'*×{mg$ G -tY޹I~sF~^RYU`G<㊱Ɠs WNEn 4岣kSuZ{,Ɲ/0~KW% Nʬ)Ĕ#G9v$[XmV1B`-`էkΛ45~, uRʄ$yIYru/ɗDԠ x1xp1QTtN95;]!+(d۸6HWĂ;Kh#8uAZtBy!EˋAE6z⽥,G2-gC>#aRJ1Qk4*Z"3w9r{*҇a'<ʖR5҃իgiɉT)!HP<. 1{ " Y\reuGJZ&O{>@S@ ͈(a㓷eKt ˷h/Sfa1עi0#_DaI*^жͪ GQ~j+ @BDESue+Yn8H<8kTny_,!}Qأ5 & qYŠ13VoRƱFW`&X4#qe9v<'?WaO‹*Z9Ʊ]aCoZ!::6+=jfgލ~\PZu~th51I깚5{ԩw݊}=[3K,SN[ƏKLO&1E!re1rBbR3 sp7ܼsZaxw@ym{w. חNӺ2Lz'i>ϬMidq< 9z9Eؓe K=uRZoQ7 g629U &9~ܖ' gɊ[Z HuNJ.|oOt+Vm=щiD+&d2rgdj=fMae[>S$5h|BW!^=C3%.7F >nVOS#dϾwY}G6ժ}kn_G͛rQ"b$6T5Nkuo\R4g -ԇ"2h}$?Զ=< a>Xy2J2$ VQVLQΌ E8VcBPKS]Dޔ05%XӇܻ D?JyA8J5#yݭX~AXX3rE՚rIa"lSPRnM0dw'vcYN_7R$u6r5K- nr>"l}ef!$x";Z +|3qI%}zW#iZBqV(}Z{ ?P R Y3ej3BZ$߅ ?$ ::K Ub /ح?Q4ys=n'/Eʄd qne{9YrreHM;?j5ƿdU63]̫WhBxoQג -,&X,]ʴݎ?&e?x/:"ųN;Y/zPhAŲRɢjbx X~)݃s:`~XvU۶֭`j֐qvw)ȡxf|`_.pN*lNn jvmmȗ۵Q~wMPvw CPlwG^o|8*A(ϞAoZwZ#<٩ *KƨHCp&kEHr)+҈M/$;*{$q#ZqVaJUȡV^q#E 0i6Qw޼N:xYt谺r8|$a'+BU'JՀFV+̵\XmXak.+E/p.7'Ygjzǵ"^V;(i-ϓC B=9Vfw2Hπ=߮nWsȝ'(~@QQ țiyw!䝆\!Ur7Ědy\Qw|]X(d8$ij$NYv@Oe\̏'sBjm.7=2th~.w9F 6R27%_ 7* N+!0V [a@hqzA>TA C2 8̝PfP` f7]9Ry_bM* I_I'ԩ OeQ:YLm7طG.D2ӿow(&KdTtͿcIwJLN>^Vow:ʀ#U'߫zǼRyϣO < :KCX-@@=cS@3IT豹Ҁ FJ)s@|b&%w#Έ'[VT2q D0kT,&G`h$41pSH[%7MmxtYY/1|)-MN?<;sQF]:&* N1t qE1@EWX\nN(-f1<ಠE%5^@0SEpǀFIfw=(+i1R>OV īcGgXQlTMFGyy<.kM8-!lЩp X tA (e״k?of̘qᔔ 5 -P!ja >Ά{qpf]bByQ{*vj-A5Ɍ/^^zN~ /#/٣u@p_\hd JzsϮ;our@ѶI6~6 ~9ALA=*Y ) i6 hCxL6ɣGXJʡ5ܳ_뇧]w@e=O[Bs$/W!@IW|<6R iKD3QRA|OQFP8?p+C@lw[FFDOybd QCUx{:^*|c1n.LfѧQ9[+<-re7zL'Ls8˥@(DDk0C Wƚ'^DnZgF3.5;y]zFNP+F ѵ%@oQ̐< IOSYD`?4oG ,NwmڻEU$rȽTɼ!C O(Ms"|+ꉋ1id v5k߄ ?|$ۭwƹS`T(C4@0Ǜ'jLj l#gf\ٳ/WOUV,Z׃FYѢӵK"B e3gQėV`łC ixB.ㆍXd3gR%\@Rv(onຑoN4b1].WvfVǎװ+8gbSiy]zU# W~e""S<.qi(VĭN!L͚Q.]zY}##w{jqϴ0W (Rޫ.,+g(fCsނi6WvT-~jB%zUT=vp fhmϩ3 !rhc֭C{vKFC }v{ ^R_qgt@ NF$n"?RL/!ԇ{^'LXpQr҆sN$IuXTG ^*qܳ_i "dL.)h@+goiʦe@c1 p?`obTt Fw~)OHNj$MFWlTYҫӧOSWZZѣG\Рm@܂7[#+'5ܼy؉m3gTޡm30щس1O W6ԥwLe?d'mA,Jhk| 1d4VW㏶*G!*.W 0n43P~ϓ>>oܫoϝ;(+w6Ȳ( `1@J~0لW JM%dܢcYF)0*~)D17Ùr#MQژ9j8ו_)?y +=-s[>UV9"h>^SGWrTKǎ-6E,:mY40*:A' ! PI䒱ߙ=wʕ۶~{U^wr2C2C@a%֌97pa([A}4 k!B6Z+'wTlܲey>{GLUhq8;r6f?G?n'?#Yv%4d~I[ކq(d\h]i>g]ʘwޜd 6t׉/Ǎ7:_UdF/Pf-)En9=B?+-a?2`+&@XI̔&wsm]ui‚vٞezbU!u `f8;kVn=5J7Q:+{c#o* C]WQ>H` WDl$ZgtMcc?x¤EeXrJY,+qTVV.I5`d HBeP߿ Oq̽SYYKo*Nޗe#Nj|\,v&RBF/1ٴ/Ȇ{sߒϜMt*hzo -1vt#a‡ˍ7PL/@.N( -27V#ckFƽx֬KmHH؞q(7l^ZyIC,Xg\P0.=:pΊ!1cnϨ֐$y<qܹعu ^KE%D[S۶+ !K^#=!,:WР D *瀬JI\#* S` _tq"KÿJxzز//Ô%s-[0RrK28#[ %[)56bR_kmJ"*k/~ٿSV<{/^>q7\<-\ϫ\nmb⺔۶m8#S$+'>3\??z۾-ÔMR'~oٚw?)'nɰabŨQ6qՄLfՓ'Q[^|qk܋)q#RF:ݿ߁<ӭG}޾}MxX]`P#wNQb`s'(lJ`=? MT<+56PrC/E<ʟR_磵pdg/%$ 6`1EA] Z,vXtk S|fڤ7[59j4}:Yei>BY⑌kaR)R/>O56Պ:v>,M{CIOǗKPSh⍭pL·xeQBpIfɥ,], {RZ&(Ջ_hd'eF u~fѐ 澰||@Y8GrNΰ%<"g1I!+_S6n_oԐBŜTJ1 㥷|YLZQ(O֮c}ݝ&b;f4p~@ 7qNk?9cMF|nXT,(O g Pk$激N>;o 2IQ 0Z:t<ڹX_}> ܋"^IXX DB/}I5s @8\ A`&Jk6@P+𓎸WOA{@@%$?^_'\DŽ h 0__U8IR //V+h@3KNT9Vס#wDC!jepV[`'`Z~ޗfsv}vp𳟪!bcqʜpUBw3tҵ}Cttb!A oѝUQFo8R*~>''@ѵYr~S17߻!AY8q&>}n[x(05 &"iKh ֡ ,uvj}GO?wpQtZrjȲg(:͢(M'JƠzLرGB@~[pKGE}fsKPJa"(NjA{^?mUxs߁*- x, ?&Sу AiI(oU=Zn)2~Yj4WFeN5h$_!q@bb#XmLݏ^tM5oT@HonkbԬÀ 47[AKR@R@06GCr22X6bnߨDW U2 gdrg lqEE tA)u`Lo<Ǡݒ쁡 H8Sb} JO~09D46]@6 (}6S7G/jz Ӧطye3ׁs 5 8Y<Wa9'/Kv[^<^~1r'[ fǀGp,CXij݇J3"jn_fhBYy9$򀖈)3{_f5{]J3-\[Ro0i 8t5ұ314Tva!GzyS^OXKGOL]Ԉ @ϚWCm^H;Mߌ2f&PURo* 1(4 FS]jvZKe߲"ܛJILBzFyŀuSDPV<ɳk?#_oip\3IENDB`$$If!vh5/ 5 #v/ #v :V l05/ 5 / / /  / 4a$$If!vh55353#v#v3:V l0553/ /  / /  / / / 4$$If!vh55353#v#v3:V l0553/ /  / /  / / / 4$$If!vh5 55#v #v#v:V l05 55/ /  / /  / / / 4Z$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4a`$$If!vh5t#vt:V l45t/ 4af4Z$$If!vh5t#vt:V l5t/ 4a`$$If!vh5t#vt:V l45t/ 4af4Z$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4a^$$If!vh5t#vt:V l#5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4aZ$$If!vh5t#vt:V l5t/ 4a:@: 1KG=K9_HmH sH tHX@X 03>;>2>: 1$$dhx@&a$CJ&mH sH uP @P 03>;>2>: 9 $ @&^B* CJBAB A=>2=>9 H@8DB 0170F0\i@\ 1KG=0O B01;8F0 :V 44 la .k@. 5B A?8A:0 \"@\ 0720=85 >1J5:B0$dhXa$CJ&mH sH uB@B "5:AB ?@8<5G0=8Odh.L@. 0B0dhCJ4Z@"4 "5:ABdhOJQJ>T@2> &8B0B0$]^a$BB@BB A=>2=>9 B5:AB 5B*CJ<OaR< Prel-Program-25XObX Prel-Program-1(CJOJQJ_HmH sH tHP?UVXYZ[l>eJ$4IP[dkl ".;IXhv #.<KUeqy/Kbq!";b{6DES N r     1 ) = w C dstG-Z[\YZ[8z{|?\]^MNOP^_`&89:PpvwxyMNO|DEF&bcd f G!H!I!!"""""""+","-"U"""""## #\#####[$\$]$^$$$$$$$$L%%%%%:&;&<&&&&&%'|'}'~''(((Z(((((&)')()Z)))))))h*i*j**+ + +++++,,,,-----.-/-`-a-b-----.9.:.;.q.....'/(/)/t////h00000E1F1G1b1c1d111112f2g2h22222-3h3i3j3374849444444445555n6o66666'7(77777O8P88888888899#9>9X9r999 : :.:::::::;;<M<`<t<<<<<<=$=7=N=m=n=N?O?R?0000000000000000 0 0 0 0 0 0 0 0 0 0  0 00 0 00 0  0  0 0 0 0 0 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 0000000000000000 0 000 0 000 0 000 0 0000 0 000 0 000000000000000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 @0@0@0 @0 000 0 000 0 000 0 000 0 00 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 00 0 00 0 000 0 00 0 000 0 000 0 00 0 00 0 000 0 000 0 000 0 000 0 000 0 000 0 000 0 00 0 000 0 000 0 000 0 000 0 000 0 000 0 000000000000000000000000000000000000000000000000800000000000000800p0p[\Z[{|cd H!I!""# ###\$]$$$%%;&<&&&}'~'((((')()++,,R?Oy00@00* Oy008G@00* Oy00@0 @0Oy00@0 O9004m0$GOy00@0 O900䶯 0$GO90 0tFD8@Oy00$H6pOy00$H6p@0 @0 Oy00$H6pOy00 tFD8@ O90 0&H6pOy00&H6p O900\0 O900GtFD8@Oy00| tFD8@ Oy00tFD8@Oy00tFD8@Oy00(G7 Oy00 tFD8@ Oy00 @f/ Oy00 tFD8@ O90*080wO90*080w  0$G _ (-*,/16o>APG$+0259BEILPU[^ k h 1[Z{N: "##N%F& (H)**+,-.0'11 35a5;67F99:9<'?AEPG%'()*,-./134678:;<=>?@ACDFGHJKMNOQRSTVWXYZ\]_PG&8@0( l  B S  ?P?U[24HIOPZ[kl!"/1DE   Z [  bd  st  Z\Y[ln z|\^oqGP^`ln8:JLwyMODFbduw F!I!""""+"-"6"8"""""# ######### $$Z$^$$$$$$$$$%%%%%%:&<&H&J&&&&&|'~'''((((((((&)()5)7)))))))))))W*Y*h*j*{*}*****+ +++B+D+S+T+++++++++++q,s,,,,,,,----/-`-b---%.&.9.;...'/)///00D1G1b1d111e2h222h3j37494K4M444555555n6o6666666'7(7z7{7775868N8P8888888888899 999999"9#9G9H9a9b9999999 : ::!:-:.:::::::m;n;;;;;;<<<`<d<<<7===l=n=========>>>>??G?H?L?R?T[kl=>deIJ#$34HIOPZ[cdjl !"-.:;HIWXghuv  "#-.;<JKTUdepqxy./JKabpq ":;abz{56CERS~  M N q r    0 1 ( ) < = v w z {     B C F G cdrtFG,-Y\X[78y|>?[^LP]`%&7:OPopuvvyLO{|CF%&ad e f F!I!!!""""*"-"T"U"""""# #[#\#####Z$^$$$$$$$K%L%%%%%9&<&&&&&$'%'{'~'''((Y(Z(((((%)()Y)Z)~))))g*j***+ +++++,,,,--,-/-_-b-----..8.;.p.q.....&/)/s/t///g0h00000D1G1a1d1111122e2h22222,3-3g3j33364944444445555m6o66666&7(767777777N8P8888888889999"9#9=9>9W9X9q9r99999 : :: :-:.:::::::;;<<L<M<_<d<s<t<<<<<<<<<<<==#=$=6===M=N=l=n=====!>">>>M?R?[t34.;v<K-P]1F"-"^$$'((()).;.G1d1R?R?poroikovporoikovporoikovporoikovporoikovporoikovporoikovporoikovporoikovVVP| L}4~Hɔi@0ܿ<XZx5D(vDn 8_   88Nư* %kG3 u4D EH$[7Z6T z\|x!DK5b >ck +bTu8Nư^`.^`.^`.^`. ^`OJQJo( ^`OJQJo( ^`OJQJo( ^`OJQJo(hh^h`. hh^h`OJQJo(hh^h`.hh^h`OJQJ^Jo(hh^h`CJ OJQJo(qhh^h`.hh^h`o(()hh^h`CJOJQJo(q hh^h`OJQJo(hh^h`B*OJQJo( hh^h`OJQJo(hh^h`o(. hh^h`OJQJo( hh^h`OJQJo(hh^h`CJ OJQJo(q8_ ~}|>ck7Z6TG3 8n DK5bu4D+bTuz\*%EH  c8 lH aE} OX9PQlIkl;K!"[\Z[{|]^NO_`9:xyNOEFcd H!I!"""","-"""# ###\$]$$$$$%%;&<&&&}'~'((((')()))))i*j* + +++,,--.-/-a-b---:.;...(/)///00F1G1c1d111g2h222i3j38494444$=R?a0a0@5'7J55@{P?@@UnknownGz Times New Roman5Symbol3& z Arial?5 z Courier New;Wingdings"qhjFs 5 rs 5 r#r40?0? 3qH(?c8 2nd International Conference poroikovVVPh                  Oh+'0  0 < H T`hpx2nd International Conference nd  poroikovnatoroNormalvVVP24Microsoft Word 10.0@@z{Q@A@# !s 5՜.+,0  hp  ibmcher 0?A 2nd International Conference    !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`bcdefghijklmnopqrstuvwxyz{|}~Root Entry F a !Data a1Table{WordDocument"SummaryInformation(DocumentSummaryInformation8CompObjj  F Microsoft Word MSWordDocWord.Document.89q